​

Immunic (IMUX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

IMUX Stock Forecast

Immunic (IMUX) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 410.20% increase from the last price of $0.98.

- $1 $2 $3 $4 $5 High: $5 Avg: $5 Low: $5 Last Closed Price: $0.98

IMUX Stock Rating

Immunic stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (91.67%), 1 Hold (8.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 11 Strong Sell Sell Hold Buy Strong Buy

IMUX Price Target Upside V Benchmarks

TypeNameUpside
StockImmunic410.20%
SectorHealthcare Stocks 35.94%
IndustryBiotech Stocks 83.61%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.98$0.98$0.98
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2525---7
Mar, 2524---6
Feb, 2524---6
Jan, 2525---7
Dec, 2425---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 21, 2022Market PerformLeerink Partners$5.00$2.09139.23%410.20%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 24, 2025William BlairOutperforminitialise
Sep 16, 2024EF HuttonBuyinitialise
Sep 04, 2024Piper SandlerOverweightOverweighthold
Aug 27, 2024B. RileyBuyinitialise
Jul 16, 2024Piper SandlerOverweightOverweighthold
Apr 05, 2024Brookline CapitalBuyinitialise
Oct 21, 2022SVB LeerinkMarket Performdowngrade
Jun 10, 2022Roth CapitalBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-1 $1 $3 $5 $7 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.11$-1.00----
Avg Forecast$-2.14$-0.96$-0.76$-0.64$1.80$4.48
High Forecast$-2.06$-0.94$-0.57$-0.31$6.34$4.48
Low Forecast$-2.19$-0.99$-0.95$-0.93$-0.60$4.48
Surprise %-1.40%4.17%----

Revenue Forecast

$0 $190M $380M $570M $760M $950M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$12.00K$397.02M$139.99M$218.83M$948.41M
High Forecast-$12.00K$397.02M$139.99M$218.83M$948.41M
Low Forecast-$12.00K$397.02M$139.99M$218.83M$948.41M
Surprise %------

Net Income Forecast

$-150M $-60M $30M $120M $210M $300M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-93.61M$-100.51M----
Avg Forecast$-93.61M$-42.95M$-33.89M$-27.48M$100.85M$198.41M
High Forecast$-91.41M$-41.87M$-25.47M$-13.74M$280.99M$198.41M
Low Forecast$-97.17M$-44.03M$-42.31M$-41.22M$-26.59M$198.41M
Surprise %-133.99%----

IMUX Forecast FAQ

Is Immunic stock a buy?

Immunic stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Immunic is a favorable investment for most analysts.

What is Immunic's price target?

Immunic's price target, set by 12 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 410.20% change from the previous closing price of $0.98.

How does Immunic stock forecast compare to its benchmarks?

Immunic's stock forecast shows a 410.20% upside, outperforming the average forecast for the healthcare stocks sector (35.94%) and outperforming the biotech stocks industry (83.61%).

What is the breakdown of analyst ratings for Immunic over the past three months?

  • April 2025: 28.57% Strong Buy, 71.43% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Immunic’s EPS forecast?

Immunic's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.76, marking a -24.00% decrease from the reported $-1 in 2024. Estimates for the following years are $-0.64 in 2026, $1.8 in 2027, and $4.48 in 2028.

What is Immunic’s revenue forecast?

Immunic's average annual revenue forecast for its fiscal year ending in December 2025 is $397.02M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $139.99M, followed by $218.83M for 2027, and $948.41M for 2028.

What is Immunic’s net income forecast?

Immunic's net income forecast for the fiscal year ending in December 2025 stands at $-33.888M, representing a -66.28% decrease from the reported $-101M in 2024. Projections indicate $-27.478M in 2026, $100.85M in 2027, and $198.41M in 2028.